Limited Competition: Cooperative Human Tissue Network (CHTN; UM1 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-23-024 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO), issued by the National Cancer Institute (NCI), is to invite competing continuation applications for cooperative agreement awards from current recipients of the NCI-supported Cooperative Human Tissue Network (CHTN). CHTN with all individual CHTN recipients (referred to as CHTN Divisions) collectively form the CHTN national resource. Presently, the organizational structure of the Network comprises six Divisions. The goal of the CHTN is to collect and distribute to investigators high-qual...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 31, 2023 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Administrative Supplement to Support the NCI Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Research
Notice NOT-CA-23-064 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 25, 2023 Category: Research Source Type: funding
Measuring Financial Hardship Among People and Families Living with AD/ADRD (R01 Clinical Trial Not Allowed)?
Funding Opportunity RFA-AG-24-036 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to develop measures of financial hardship associated with AD/ADRD that are responsive to the dyadic and family-level financial management arrangements that are common as AD/ADRD progresses. In order to accurately measure financial hardship among people and families living with AD/ADRD, validated screeners are needed to capture unique hardships associated with AD/ADRD that are not measured in screeners developed for people with cancer or in screeners developed for healthy households. This Notice of Funding Opp...
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 17, 2023 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for Advancing Cancer Control Equity Research through Transformative Solutions Coordination Center (U24 Clinical Trial Optional)
Notice NOT-CA-23-068 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 12, 2023 Category: Research Source Type: funding
Notice of Intent to Publish a Funding Opportunity Announcement for Advancing Cancer Control Equity Research Through Transformative Solutions (U19 Clinical Trial Optional)
Notice NOT-CA-23-066 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 12, 2023 Category: Research Source Type: funding
Pre-application Webinar for RFA-CA-24-005 "Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional)"
Notice NOT-CA-23-065 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - May 5, 2023 Category: Research Source Type: funding
Integrating Health Disparities into Immuno-Oncology (HDIO) (P20 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-23-038 from the NIH Guide for Grants and Contracts. The scientific objectives of this P20 FOA are to support planning and feasibility studies to integrate cancer health disparities into immuno-oncology research studies. The P20 project will enable complementary, multi-disciplinary research teams to address inter-disciplinary research to integrate cancer health disparities into immuno-oncology research. It is anticipated these feasibility or pilot studies will support the exploration of novel or high-risk research hypotheses. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 27, 2023 Category: Research Source Type: funding
Request for Information (RFI): Needs and Challenges in Obtaining and Testing Clinical-Grade RNA-based Cancer Vaccine Formulations to Support Translational and Clinical Research
Notice NOT-CA-23-063 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 24, 2023 Category: Research Source Type: funding
Small Business Transition Grant For Early Career Scientists (R42 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-23-035 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) intends to support early-career academic scientists interested in transitioning to entrepreneurship while also supporting the transfer of technology from academic laboratories into small businesses. Both small businesses and universities are drivers of technological innovation in the United States (U.S.), often working together to advance innovative ideas into products that can benefit the U.S. population. While most NIH funding supports basic research in...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 21, 2023 Category: Research Source Type: funding
SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
Funding Opportunity RFA-CA-23-034 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (NOFO) solicits Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek additional funding to support the next stage of development for cancer-relevant projects that were previously funded under SBIR or STTR Phase II awards from any Federal agency. The purpose of this NOFO is to facilitate the transition of SBIR or STTR Phase II projects to the commercialization stage. This NOFO is expected to promote partnerships between Federally-funded SBIR or STTR Phase II ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 21, 2023 Category: Research Source Type: funding
Notice of Correction to RFA-CA-22-050, NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01 Clinical Trial Optional)".
Notice NOT-CA-23-061 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 21, 2023 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Administrative Supplements for the Dog Oncology Grant Supplement (DOGS) Program
Notice NOT-CA-23-059 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 21, 2023 Category: Research Source Type: funding
Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional)
Funding Opportunity RFA-CA-24-005 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) supports the development of cancer-relevant technologies suitable for use in low- and middle-income countries (LMICs). Specifically, the FOA solicits applications for projects to adapt, apply, and validate existing or emerging technologies into a new generation of user-friendly, low-cost technologies for preventing, detecting, diagnosing, and/or treating cancers in people living in LMICs.Applicants should have a working assay or device prototype (not necessarily already capable of cancer application...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 20, 2023 Category: Research Source Type: funding
Cancer Immunoprevention Network (CIP-Net) ?Research Projects (UG3/UH3 Clinical Trials Not Allowed)
Funding Opportunity RFA-CA-23-029 from the NIH Guide for Grants and Contracts. The purpose of the Cancer Immunoprevention Network (CIP-Net) is to support a deeper understanding of basic mechanisms of immunoprevention, discover novel immunoprevention strategies, and foster a community of cancer immunoprevention researchers. ?The UG3/UH3 research projects will enable de novo discovery of immune pathways, immunoprevention mechanisms, or investigation of new vaccine or immunomodulatory targets or agents. Applicants responding to this FOA must apply for both the UG3 and UH3 phases together in a single application. Achievemen...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 20, 2023 Category: Research Source Type: funding
Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
Funding Opportunity PAR-23-170 from the NIH Guide for Grants and Contracts. The Office of Disease Prevention (ODP) and participating National Institutes of Health (NIH) Institutes, Centers, and Offices (ICs) are issuing this R01 to solicit applications to address barriers and facilitators that impede use or uptake of cancer screening and preventive services in populations that experience health disparities. Interventions should include screening, preventive services, or other healthcare processes, including timely follow-up of abnormal findings, and referral to accessible care. Projects are encouraged to leverage colla...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 19, 2023 Category: Research Source Type: funding
